[1] 章文成,肖泽芬.食管癌根治术后预防性放疗应用的相关性研究(二)——食管癌术后失败模式与术后放疗.中华放射肿瘤学杂志,2011,20:148-151.
[2] 陈钢,王洲,刘相燕,等.胸中段食管鳞癌Ivor-Lewis手术后肿瘤复发 196例临床分析.癌症,2006,25:96-99.
[3] Mariette C,Balon JM,Piessen G,et al.Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease.Cancer,2003,97:1616-1623.
[4] 李维贵,张德洲,马俊杰,等.食管癌根治术后放射治疗临床疗效分析.中华放射肿瘤学杂志,2004,13:342-343.
[5] 乔红梅,富强,宋丽萍.食管癌根治术后放射治疗的疗效分析.现代肿瘤医学,2010,18:1982-1984.
[6] Teniere P,Hay JM,Fingerhut A,et al. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by multicenter controlled trail. French university association for surgical research. Surg Gynecol Obster,1991,173:123-130.
[7] 陈克能,师晓天,窦运喜,等.食管癌切除术后纵隔及双锁上下区照射的远期生存.中国肿瘤临床,2004,31:1027-1029.
[8] 梅泽如,项其昌,吴维继,等.食管癌术后预防性放疗前瞻性研究.中华放射肿瘤学杂志,1997,6:188-189.
[9] 肖泽芬,杨宗贻,梁军,等.食管癌根治术后预防性放疗的临床价值.中华肿瘤杂志,2002,24:608-611.
[10] 李云英,林祥松,佘志廉,等.食管癌根治术后预防性T型野放疗意义的探讨.中华放射肿瘤学杂志,1996,5:53-54.
[11] 肖泽芬,杨宗贻,王绿化,等.食管癌术后淋巴结转移对生存率的影响和放疗的意义.中华肿瘤杂志,2004,26:112-115.
[12] 陈俊强,潘建基,陈明强,等.胸段食管鳞癌淋巴结转移数和区域与术后放疗价值的临床研究.中华放射肿瘤学杂志,2010,19:105-109.
[13] 陆进成,钱普东,查文武,等.食管癌根治术后预防性放疗随机研究的Meta分析.偱证医学,2005,5:166-168.
[14] 吉占全,顾天瑞,马德明,等.术后预防性放疗对食管癌根治术后预后的影响(568例临床观察).实用肿瘤杂志,2007,22:250-252.
[15] 王军,张辛,韩春,等.根据胸段食管癌淋巴结转移规律探讨术后预防性照射范围和适应证.中华放射肿瘤学杂志,2009,18:265-269.
[16] 王军,张献波,祝淑钗,等.胸段食管癌淋巴结转移规律研究现状.中华放射肿瘤学杂志,2008,17:75-78.
[17] Fok M,Sham JS,Choy D,et al. Postoperative radiotherapy for carcinoma of the esophagus:a prospective,randomized controlled study.Surgery,1993,113:138-147.
[18] Zieren HU,Muller JM,Jacobi CA,et al. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J Surg,1995,19:444-449.
[19] 郑明章,林柏翰,陈志坚,等.食管癌术后放疗靶区的确定.广东医学,2004,25:301-302.
[20] 刘明,李彩英,周道安,等.食管癌根治术后纵隔淋巴结转移的特点.中华放射肿瘤学杂志,2001,10:83-84.
[21] 乔学英,周道安,蔺强,等.食管癌术后预防照射范围的临床研究.中华放射肿瘤学杂志,2006,15:389-392.
[22] 陈俊强,陈明强,李云英,等.胸段食管癌三野根治术后放疗靶区的临床研究.中华放射医学与防护杂志,2006,26:374-377.
[23] 王锦泰,陈忠华,李东石,等.食管癌术放射治疗照射范围的探讨.福州总医院学报,1999,6:37.
[24] Leonard GD,Reilly EM. Post-operative chemotherapy improves disease free survival,but not overall in people with oesophageal squamous cell carcinoma.Cancer Treat Rev,2004,30:473-477.
[25] Lee J,Lee KE,Im YH,et al. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma. Ann Thorac Surg,2005,80:1170-1175.
[26] 方文涛,陈文虎,蒋勇,等.胸腹二野淋巴结清扫结合术后辅助化疗治疗食管癌.中华胸心血管外科杂志,2005,21:268-271.
[27] 黄伟钊,傅剑华,胡祎,等.食管癌术后辅助化疗价值的Meta分析.癌症,2006,25:1303-1306.
[28] 毛伟敏,程蕾,食管癌术后辅助治疗的Meta分析.肿瘤学杂志,2012,18:94-99.
[29] 张杰,陈海泉,张亚伟,等.食管癌术后辅助化疗的荟萃分析和来自复旦大学附属肿瘤医院的配对研究.中国癌症杂志,2008,18:276-281.
[30] 李苏宜,孙新臣,刘琳.食管癌内科治疗及综合治疗进展.癌症,2006,25:509-515.
[31] 王肇炎.食管癌药物治疗的前景困难及对策.中华肿瘤杂志,2011,33:157-159.
[32] Richel DJ,Verenne WL. Systemic treatment of oesophageal cancer. Eur Gastroenterol Hepatol,2004,16:249-254.
[33] Armanios M,Xu R,Forastiere AA,et al. Adjuvant chemotherapy for resected adenocarcinoma of the esophagus,gastro-esophageal junction,and cardia: phase Ⅱ trial(E8296) of the eastern cooperative oncology group. J Clin Oncol,2004,22:4495-4499.
[34] Rice TW,Adelstein DJ,Chidel MA,et al. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma.J Thorac Cardiovase Surg,2003,126:1590-1596.
[35] Bedard EL,Inculet RI,Malthaner RA,et al. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma.Cancer,2001,91:2423-2430.
[36] 曹秀峰,吕进,朱斌,等.局部晚期食管鳞状细胞癌术后放疗和化疗的前瞻性研究.中华肿瘤杂志,2010,32:452-455.
[37] 黄健,王茂生,林华明,等.以手术为主的N1期食管癌综合治疗模式探讨.肿瘤防治杂志,2007,9:167-169.
[38] 金建华,许锡元,刘建跃,等.食管癌术后放化疗疗效及其预后因素分析.中华放射肿瘤学杂志,2009,18:113-114.
[39] 王玉祥,祝淑钗,李任,等.食管癌根治术后放疗与放化疗疗效比较.肿瘤防治研究,2005,32:171-174.
[40] Tachibana M,Yoshimura H,Kinugasa S,et al. Postoperative chemotherapy vs. chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial.EJSO,2003,29:580-587. |
2012, Vol. 21 
